Modern Polycystic Ovary Syndrome Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization

    April 2026 in “ Biomolecules ”
    Abdel Halim Harrath, Maroua Jalouli, Mohammed Al‐Zharani, Md Ataur Rahman
    Studysummary This review highlights recent advancements in molecular understanding and treatment approaches for PCOS, including innovative drug delivery systems and AI-driven precision medicine, but provides no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 11

    1. Letrozole-Assisted Ovulation Induction Combined With Lifestyle Modification in Women With PCOS: A Review Journal of Education Health and Sport · 2026
    2. Metformin Use in Women with Polycystic Ovary Syndrome: Opportunities, Benefits, and Clinical Challenges PubMed · 2025
    3. Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease Pharmaceutics · 2024
    4. Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism · 2023
    5. Recommendations From The 2023 International Evidence-Based Guideline For The Assessment And Management Of Polycystic Ovary Syndrome European journal of endocrinology · 2023
    6. Insulin Resistance and Elevated Androgen Levels: A Major Cause of Polycystic Ovary Syndrome Frontiers in Endocrinology · 2021
    7. Sex Hormone-Binding Globulin as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome International Journal of Molecular Sciences · 2020
    8. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013
    9. Use of Ethinylestradiol/Drospirenone Combination in Patients with Polycystic Ovary Syndrome Therapeutics and clinical risk management · 2008
    10. The Pathophysiology of Polycystic Ovary Syndrome: Understanding PCOS and Its Endocrinology Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004
    11. Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism Fertility and Sterility · 1997